Megan Dupuis named Internal Medicine Residency Program director
She will assume her new role in July 2026 from John McPherson, MD, who has served in the program director role since 2013.
Study provides new data on COVID outcomes for cancer patients
A new prospective clinical trial with updated data on COVID-19 hospitalizations and deaths among patients with cancer confirms the importance of vaccination and sheds light on which conditions put patients most at risk.
Medicine faculty receive Komen leadership grants
Susan G. Komen has awarded $10.8 million in new research grants that will help propel innovative science and deliver hope to those facing breast cancer. The grant recipients include Department of Medicine faculty Drs. Tuya Pal (Genetic Medicine and Clinical Pharmacology) and Ben Ho Park (Hematology and Oncology).
Study shows sharp increase in appendix cancer for Generation X and millennials
According to a newly published study in the Annals of Internal Medicine by Andreana Holowatyj, PhD, MSCI (Hematology and Oncology), and colleagues, cases of appendiceal cancer tripled for Americans born between 1976 to 1984, and quadrupled for those born between 1981 and 1989.
Andreana Holowatyj named ‘40 Under 40 In Cancer’ winner
Andreana Holowatyj, PhD, MSCI (Hematology and Oncology), has been named to the 40 Under 40 In Cancer Class of 2025 by the Association for Value-Based Cancer Care.
Academy for Excellence in Education announces 2025 award winners and new members
Three Department of Medicine faculty are among the 13 new members inducted into the AEE. They are: Lindsay Bischoff, MD (Diabetes, Endocrinology and Metabolism), Barbara Gisella Carranza Leon, MD (Diabetes, Endocrinology and Metabolism), Megan Dupuis, MD, PhD (Hematology and Oncology).
Three Vanderbilt-affiliated cellular therapy programs receive reaccreditation
The cellular therapy programs at Vanderbilt-Ingram Cancer Center, Monroe Carell Jr. Children’s Hospital at Vanderbilt, and the VA Tennessee Valley Healthcare System have received reaccreditation from the Foundation for the Accreditation of Cellular Therapy (FACT).
Kimberly Dahlman elected to board of International Association of Medical Science Educators
Kimberly Dahlman, PhD, associate professor of Medicine in the Division of Hematology and Oncology, will begin serving her three-year term upon the closing of the association’s annual conference on June 17.